Publications
- 
                        Alvarez-Larrán A, Villamor N, Hernández-Boluda JC, Ferrer A, Camós-Guijosa M, Campo E and López-Guillermo A. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.Clinical Lymphoma . 2(3): 178-182. Number of citations: 7 
- 
                        Montoto S, Camós-Guijosa M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E and Montserrat E. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin diseaseCANCER . 88(9): 2142-2148. Number of citations: 18 [doi:10.1002/(SICI)1097-0142(20000501)88:9<2142::AID-CNCR21>3.0.CO;2-M] 
- 
                        Hernández-Boluda JC, Cervantes F, Camós-Guijosa M, Costa D, Rafel M and Montserrat E. [Philadelphia chromosome-positive chronic myeloid leukemia in the elderly: presenting features, natural history and survival].MEDICINA CLINICA . 112(15): 565-567. Number of citations: 2 
- 
                        Ferrer A, López-Guillermo A, Bosch F, Montoto S, Hernández-Boluda JC, Camós-Guijosa M, Miquel R, Campo E and Montserrat E. [Non-gastric mucosa-associated lymphoid tissue (MALT) lymphomas: analysis of 14 patients].MEDICINA CLINICA . 112(15): 577-580. Number of citations: 9 
- 
                        Camós-Guijosa M, Cervantes F, Montoto S, Hernández-Boluda JC, Villamor N and Montserrat E. Acute lymphoid leukemia following polycythemia veraLEUKEMIA & LYMPHOMA . 32(3-4): 395-398. Number of citations: 13 
